204 related articles for article (PubMed ID: 10469609)
1. Transgenic expression of human MGMT blocks the hypersensitivity of PMS2-deficient mice to low dose MNU thymic lymphomagenesis.
Qin X; Zhou H; Liu L; Gerson SL
Carcinogenesis; 1999 Sep; 20(9):1667-73. PubMed ID: 10469609
[TBL] [Abstract][Full Text] [Related]
2. Mice defective in the DNA mismatch gene PMS2 are hypersensitive to MNU induced thymic lymphoma and are partially protected by transgenic expression of human MGMT.
Qin X; Liu L; Gerson SL
Oncogene; 1999 Jul; 18(30):4394-400. PubMed ID: 10439048
[TBL] [Abstract][Full Text] [Related]
3. Heterozygous DNA mismatch repair gene PMS2-knockout mice are susceptible to intestinal tumor induction with N-methyl-N-nitrosourea.
Qin X; Shibata D; Gerson SL
Carcinogenesis; 2000 Apr; 21(4):833-8. PubMed ID: 10753224
[TBL] [Abstract][Full Text] [Related]
4. Mice over-expressing human O6 alkylguanine-DNA alkyltransferase selectively reduce O6 methylguanine mediated carcinogenic mutations to threshold levels after N-methyl-N-nitrosourea.
Allay E; Veigl M; Gerson SL
Oncogene; 1999 Jun; 18(25):3783-7. PubMed ID: 10391687
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of human O6-alkylguanine DNA alkyltransferase (AGT) prevents MNU induced lymphomas in heterozygous p53 deficient mice.
Reese JS; Allay E; Gerson SL
Oncogene; 2001 Aug; 20(38):5258-63. PubMed ID: 11536039
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of lymphomagenesis by methylnitrosourea in mice transgenic for LMO1 is blocked by O6-alkylguanine DNA-alkyltransferase.
Allay E; Reese JS; McGuire EA; Koç ON; Sedransk N; Gerson SL
Oncogene; 1997 Oct; 15(17):2127-32. PubMed ID: 9366529
[TBL] [Abstract][Full Text] [Related]
7. Rapid repair of O6-methylguanine-DNA adducts protects transgenic mice from N-methylnitrosourea-induced thymic lymphomas.
Liu L; Allay E; Dumenco LL; Gerson SL
Cancer Res; 1994 Sep; 54(17):4648-52. PubMed ID: 8062258
[TBL] [Abstract][Full Text] [Related]
8. A defect in a single allele of the Mlh1 gene causes dissociation of the killing and tumorigenic actions of an alkylating carcinogen in methyltransferase-deficient mice.
Kawate H; Itoh R; Sakumi K; Nakabeppu Y; Tsuzuki T; Ide F; Ishikawa T; Noda T; Nawata H; Sekiguchi M
Carcinogenesis; 2000 Feb; 21(2):301-5. PubMed ID: 10657972
[TBL] [Abstract][Full Text] [Related]
9. Alkyltransferase transgenic mice: probes of chemical carcinogenesis.
Gerson SL; Zaidi NH; Dumenco LL; Allay E; Fan CY; Liu L; O'Connor PJ
Mutat Res; 1994 Jun; 307(2):541-55. PubMed ID: 7514728
[TBL] [Abstract][Full Text] [Related]
10. The immature thymocyte is protected from N-methylnitrosourea-induced lymphoma by the human MGMT-CD2 transgene.
Zaidi NH; Allay E; Ayi TC; Li BF; Dumenco LL; Sy MS; Gerson SL
Carcinogenesis; 1995 May; 16(5):1047-53. PubMed ID: 7767963
[TBL] [Abstract][Full Text] [Related]
11. Influence of sex and carcinogen treatment protocol on tumor latency and frequency of K-ras mutations in N-methyl-N-nitrosourea-induced lymphomas.
Romach E; Moore J; Rummel S; Richie E
Carcinogenesis; 1994 Oct; 15(10):2275-80. PubMed ID: 7955066
[TBL] [Abstract][Full Text] [Related]
12. Microsatellite instability detected in tumor-related genes in C57BL/6J mice with thymic lymphoma induced by N-methyl-N-nitrosourea.
Zhang S; Huo X; Li Z; Li X; Tang W; Li C; Guo M; Du X; Chen Z
Mutat Res; 2015 Dec; 782():7-16. PubMed ID: 26498208
[TBL] [Abstract][Full Text] [Related]
13. The prevention of thymic lymphomas in transgenic mice by human O6-alkylguanine-DNA alkyltransferase.
Dumenco LL; Allay E; Norton K; Gerson SL
Science; 1993 Jan; 259(5092):219-22. PubMed ID: 8421782
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the DNA mismatch repair factor, PMS2, confers hypermutability and DNA damage tolerance.
Gibson SL; Narayanan L; Hegan DC; Buermeyer AB; Liskay RM; Glazer PM
Cancer Lett; 2006 Dec; 244(2):195-202. PubMed ID: 16426742
[TBL] [Abstract][Full Text] [Related]
15. Health span and life span in transgenic mice with modulated DNA repair.
Walter CA; Zhou ZQ; Manguino D; Ikeno Y; Reddick R; Nelson J; Intano G; Herbert DC; McMahan CA; Hanes M
Ann N Y Acad Sci; 2001 Apr; 928():132-40. PubMed ID: 11795504
[TBL] [Abstract][Full Text] [Related]
16. Genetic susceptibility to thymic lymphomas and K-ras gene mutation in mice after exposure to X-rays and N-ethyl-N-nitrosourea.
Shimada Y; Nishimura M; Kakinuma S; Ogiu T; Fujimoto H; Kubo A; Nagai J; Kobayash K; Tano K; Yoshinaga S; Bhakat KK
Int J Radiat Biol; 2003 Jun; 79(6):423-30. PubMed ID: 12963544
[TBL] [Abstract][Full Text] [Related]
17. Influence of murine leukemia proviral integrations on development of N-methyl-N-nitrosourea-induced thymic lymphomas in AKR mice.
Richie ER; Angel JM; Cloyd MW
J Virol; 1991 Nov; 65(11):5751-6. PubMed ID: 1656068
[TBL] [Abstract][Full Text] [Related]
18. Role of DNA repair in carcinogen-induced ras mutation.
Engelbergs J; Thomale J; Rajewsky MF
Mutat Res; 2000 May; 450(1-2):139-53. PubMed ID: 10838139
[TBL] [Abstract][Full Text] [Related]
19. Roles of MGMT and MLH1 proteins in alkylation-induced apoptosis and mutagenesis.
Takagi Y; Takahashi M; Sanada M; Ito R; Yamaizumi M; Sekiguchi M
DNA Repair (Amst); 2003 Oct; 2(10):1135-46. PubMed ID: 13679151
[TBL] [Abstract][Full Text] [Related]
20. DNA Alkylating Agent Protects Against Spontaneous Hepatocellular Carcinoma Regardless of O6-Methylguanine-DNA Methyltransferase Status.
Herzig MC; Zavadil JA; Street K; Hildreth K; Drinkwater NR; Reddick T; Herbert DC; Hanes MA; McMahan CA; Reddick RL; Walter CA
Cancer Prev Res (Phila); 2016 Mar; 9(3):245-52. PubMed ID: 26667451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
